To study the efficacy and pharmacoeconomic aspects of treatment of patients with chronic brain ischemia.
Material and methods
Forty five patients with chronic brain ischemia were enrolled in the open-label prospective study. Twenty one of them were treated with intranvenous vinpocetine over 10 days.
Treatment with vinpocetine resulted in improvement of inscomnia, depression and anxiety. The reproduction of numbers and the parameters of brief memory have also improved. The study showed the economic benefits of inpatient substitution technologies, i.e. day care.
Our study showed the efficacy of vinpocetine in the treatment of chronic brain ischemia.
Сerebrovascular diseases, vinpocetine.